Home › Bladder Cancer › NCT06427824
Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
Comprehensive Geriatric Assessment Utilization for Bladder Cancer Patients Undergoing Radical Cystectomy: A Randomized Controlled Trial
Who can join
Ages 65 and older · All sexes
Full eligibility criteria
Inclusion Criteria * Participants capable of giving consent * Participants undergoing radical cystectomy (both for curative and palliative intent) for bladder cancer diagnosed by tissue pathology with urinary diversion at the University of Chicago * Participants undergoing neoadjuvant chemotherapy will be included * Participants will be included regardless of gender, race or ethnicity * Participants greater than or equal to 65 years of age Exclusion Criteria * Radical cystectomy for non-oncologic indications * Palliative cystectomy for cancers other than bladder cancer (i.e. prostate, rectal, cervical)
About the study
This study focuses on providing an educational program for people/participants with bladder cancer who plan to have a cystectomy (surgery) as part of their standard care. Participants in this study will watch videos designed to teach them strategies to help lower their risk of experiencing negative side effects (such as mobility problems, issues with taking medication, and poor quality of life) before and after they have surgery. They will also be asked to fill out questionnaires.
What is being tested
- Educational Video Modules on Risk Prevention Before and After Cystectomy (Surgery) (other)
- Geriatric Service/ Discharge Planning (other)
- Questionnaires (other)
Sponsor: University of Chicago · Participants: 85 · Started: Aug 9, 2024
Contact the study team
- Piyush K Agarwal, MD · Phone: 773-702-3080
Official record on ClinicalTrials.gov — NCT06427824
Locations in the U.S.
| Illinois | University of Chicago Medicine Comprehensive Cancer Center, Chicago |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.